22.45
Precedente Chiudi:
$22.00
Aprire:
$22.06
Volume 24 ore:
2.29M
Relative Volume:
2.07
Capitalizzazione di mercato:
$2.83B
Reddito:
$2.25B
Utile/perdita netta:
$27.39M
Rapporto P/E:
133.79
EPS:
0.1678
Flusso di cassa netto:
$136.77M
1 W Prestazione:
-5.11%
1M Prestazione:
-17.55%
6M Prestazione:
+2.09%
1 anno Prestazione:
+15.07%
Privia Health Group Inc Stock (PRVA) Company Profile
Nome
Privia Health Group Inc
Settore
Industria
Telefono
571-366-8850
Indirizzo
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, BTSG, TEM, HQY, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
PRVA
Privia Health Group Inc
|
22.45 | 3.11B | 2.25B | 27.39M | 136.77M | 0.1678 |
|
VEEV
Veeva Systems Inc
|
230.47 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
62.43 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
52.05 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
104.63 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
HNGE
Hinge Health Inc
|
89.33 | 5.81B | 646.34M | -512.40M | 202.76M | -6.6871 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-01-10 | Iniziato | Needham | Buy |
| 2024-12-16 | Iniziato | Macquarie | Outperform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-22 | Iniziato | Citigroup | Buy |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Ripresa | Jefferies | Buy |
| 2024-02-22 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-06-13 | Iniziato | Evercore ISI | Outperform |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-03-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-02-03 | Iniziato | Goldman | Buy |
| 2022-12-09 | Iniziato | Stifel | Buy |
| 2022-12-08 | Iniziato | UBS | Buy |
| 2022-09-07 | Ripresa | Truist | Buy |
| 2022-05-03 | Iniziato | BofA Securities | Buy |
| 2022-04-28 | Iniziato | BTIG Research | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-30 | Iniziato | Guggenheim | Buy |
| 2022-02-22 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2022-01-03 | Iniziato | Jefferies | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-05-24 | Iniziato | Canaccord Genuity | Buy |
| 2021-05-24 | Iniziato | Credit Suisse | Outperform |
| 2021-05-24 | Iniziato | JP Morgan | Overweight |
| 2021-05-24 | Iniziato | Piper Sandler | Overweight |
| 2021-05-24 | Iniziato | Truist | Buy |
| 2021-05-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Privia Health Group Inc Borsa (PRVA) Ultime notizie
Privia Health Group, Inc. Revenue Breakdown – NASDAQ:PRVA - TradingView
PRVA|Privia Health Group Inc|Price:25.500|Chg%:+0.530 - TradingKey
Privia Health Group Inc (PRVA) Cash Flow - TradingKey
Privia Health Group Inc (PRVA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Privia Health Group Inc (PRVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PRVA|Privia Health Group Inc|Price:25.080|Chg%:-0.420 - TradingKey
Privia Health stock rebounded from lows to $25.50 as support holds above medium-term averages - Traders Union
3 Reasons to Avoid PRVA and 1 Stock to Buy Instead - Yahoo Finance
Privia Health Group Inc (PRVA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Citi Maintains Privia Health(PRVA.US) With Buy Rating, Raises Target Price to $35 - Moomoo
Privia Health Group Inc (PRVA) Shares Fall 3.6% -- What GF Score of 88 Tells Investors - GuruFocus
(PRVA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Privia Health Group (PRVA) Declines 1.18% as Stock Nears Key Support at $25.55Insider Selling Alerts - dars.gov.et
Top 3 Health Care Stocks That May Implode This Month - Benzinga
Price to book forward of Privia Health Group, Inc. – NASDAQ:PRVA - TradingView
Privia Health Group Insider Sold Shares Worth $588,679, According to a Recent SEC Filing - Moomoo
Privia Health (PRVA) CFO Mountcastle sells 21,275 shares under 10b5-1 plan - Stock Titan
What Does a Privia Health Insider's Sale of Company Shares for $3.6 Million Mean for Investors? - AOL.com
RBC Capital Keeps Their Buy Rating on Privia Health Group (PRVA) - The Globe and Mail
Privia Health Group stock hits 52-week high at $27.71 By Investing.com - Investing.com India
Form 144 Privia Health Group For: 9 July By Investing.com - Investing.com South Africa
Form 4 Privia Health Group Inc For: 9 July By Investing.com - Investing.com Nigeria
Privia Health CFO Mountcastle sells $16,542 in company stock By Investing.com - Investing.com Australia
David Mountcastle sells multiple PRVA shares (PRVA) including 24,734 on 07/02/2026 - Stock Titan
Privia Health CFO Mountcastle sells $16,542 in company stock - Investing.com UK
Privia Health (PRVA) CFO sells 600 shares, keeps over 186K stake - Stock Titan
Privia Health Group stock hits 52-week high at $27.71 - Investing.com
Privia Health Group (PRVA) Holds Steady Amid Sector Shifts – Key Levels in FocusFundamental Weighted - dars.gov.et
RBC Capital Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $31 - Moomoo
Form 144 Privia Health Group For: 7 July By Investing.com - Investing.com South Africa
Form 4 Privia Health Group Inc For: 7 July By Investing.com - Investing.com Nigeria
Privia Health Group EVP & CFO David Mountcastle sells $680k in shares - Investing.com
Shawn Morris resigns from Privia Health Group board and compliance committee - TradingView
Board member Shawn Morris exits Privia Health (NASDAQ: PRVA) role - Stock Titan
Privia Health Group (PRVA) director reports 112,759-share option exercise and sale - Stock Titan
Privia Health Group (PRVA) CFO sells 24,734 shares in planned trade - Stock Titan
PRVA (NASDAQ: PRVA) Form 144: 600 vested shares; insider sold 24,734 on 07/02/2026 - Stock Titan
Privia Health to report Q2 2026 results on August 6 - scanx.trade
PRVA Q1 2026 Earnings: EPS Misses Estimates by Wide Margin; Shares Edge LowerPerformance Review - dars.gov.et
Privia Health to Report Second Quarter 2026 Results on Thursday, August 6 - The Manila Times
Privia Health sets Aug. 6 earnings call and outlook update - Stock Titan
Press Release: Privia Health to Report Second Quarter 2026 Results on Thursday, August 6 - Moomoo
Privia Health Q1 2026 slides show operational strength, earnings disappoint - Investing.com
Privia Health stock rises 1.79 percent to $27.36 as PriviaHealth shares upbeat Independence Day message - Traders Union
3 Quality Stocks Built For A Pricey Market - Sahm
Form 144 Privia Health Group For: 2 July By Investing.com - Investing.com Nigeria
Privia Health Group Inc Azioni (PRVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):